Projects per year
An Open-Label, Multicenter, Phase I/Ib Trial Evaluating the Safety, Efficacy, and Pharmacokinetics of Escalating Doses of mosunetuzumab (BTCT4465A) as a Single Agent and Combined with Atezolizumab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Fleming, S. A., Patil, S. & Kennedy, N.
6/03/19 → 31/12/22
Patil, S. & Kennedy, N.
20/02/19 → 29/02/24
Study of using Cyclophosphamide After Sibling-donor allogenic stem-cell Transplantation (CAST) in patients with acute leukaemia and Myelodysplasia: a randomised study comparing cyclosporin and methotrexate to cyclosporin and post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis.
23/10/18 → 23/10/23
CAST – A Randomised Phase 3 Trial of Cyclophosphamide after Sibling Allogeneic Haematopoietic Stem Cell Transplant
13/06/18 → 31/12/22